UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
British journal of haematology, ISSN 0007-1048, 10/2017, Volume 179, Issue 1, pp. 120 - 130
standard‐risk | first complete remission | haematopoietic stem cell transplantation | haploidentical donor | acute lymphoblastic leukaemia | standard-risk | Life Sciences & Biomedicine | Hematology | Science & Technology | Haplotypes | Recurrence | Humans | Middle Aged | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Transplantation, Homologous | Incidence | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Unrelated Donors | Retrospective Studies | Graft vs Host Disease - diagnosis | Graft vs Host Disease - etiology | Siblings | Graft Survival | Treatment Outcome | Combined Modality Therapy | Remission Induction | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Adolescent | Survival Analysis | Graft vs Host Disease - prevention & control | Hematopoietic Stem Cell Transplantation - methods | Transplantation Conditioning | Adults | Transplantation | Comparative analysis | Hematopoietic stem cells | Stem cells | Index Medicus
Journal Article
Biology of blood and marrow transplantation, ISSN 1083-8791, 2017, Volume 23, Issue 4, pp. 648 - 653
Hematology, Oncology and Palliative Medicine | Active disease | Acute myeloid leukemia | Haploidentical transplantation | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Age Factors | Hematopoietic Stem Cell Transplantation - standards | Humans | Middle Aged | Male | Hematopoietic Stem Cell Transplantation - mortality | Transplantation, Haploidentical - mortality | Cyclophosphamide - therapeutic use | Graft vs Host Disease | Young Adult | Transplantation, Haploidentical - methods | Adult | Female | Retrospective Studies | Leukemia, Myeloid, Acute - therapy | Risk Factors | Treatment Outcome | Leukemia, Myeloid, Acute - mortality | T-Lymphocytes - cytology | Survival Analysis | Aged | Hematopoietic Stem Cell Transplantation - methods | Transplantation, Haploidentical - standards | Histocompatibility | Tissue Donors - supply & distribution | Cyclophosphamide | T cells | Hematopoietic stem cells | Analysis | Mortality | Index Medicus
Journal Article
Bone marrow transplantation (Basingstoke), ISSN 0268-3369, 05/2018, Volume 53, Issue 5, pp. 521 - 534
Immunology | Life Sciences & Biomedicine | Hematology | Oncology | Transplantation | Biophysics | Science & Technology | Humans | Isoantibodies - analysis | Hematopoietic Stem Cell Transplantation - adverse effects | Transplantation, Haploidentical - adverse effects | Bone Marrow Transplantation - adverse effects | HLA Antigens - immunology | Treatment Outcome | Graft Rejection - immunology | Tissue Donors | Viral antibodies | Usage | Analysis | Antibodies | Practice guidelines (Medicine) | Bone marrow | Research | Hematopoietic stem cells | Antigens | Cell survival | Transplants & implants | Progenitor cells | Blood | Hemopoiesis | Rejection | Isoimmunization | Offspring | Grafts | Histocompatibility antigen HLA | Females | Index Medicus | Life Sciences
Journal Article
Bone marrow transplantation (Basingstoke), ISSN 0268-3369, 06/2016, Volume 51, Issue 6, pp. 778 - 785
Immunology | Life Sciences & Biomedicine | Hematology | Oncology | Transplantation | Biophysics | Science & Technology | Hematopoietic Stem Cell Transplantation - statistics & numerical data | Hematopoietic Stem Cell Transplantation - utilization | Humans | Bone Marrow Transplantation | Global Health - statistics & numerical data | Surveys and Questionnaires | Tissue Donors | Transplantation, Haploidentical | Peripheral Blood Stem Cell Transplantation | Transplantation, Homologous | Cord Blood Stem Cell Transplantation | Surveys | Health care industry | Forecasts and trends | Medical statistics | Hematopoietic stem cells | Usage | Analysis | Stem cells | Research | Data entry | Index Medicus | emerging technologies | Non Governmental Organization | SWOT analysis | Worldwide Network for Blood and Marrow Transplantation WBMT | global | transplant rates | hematopoietic stem cell transplantation (HSCT) | haploidentical transplants | cord blood transplants | trends | WHO
Journal Article
Bone marrow transplantation (Basingstoke), ISSN 0268-3369, 02/2016, Volume 51, Issue 6, pp. 786–792 - 792
Hematology | Transplantation | Journal Article | Amyloidosis - therapy | Hematopoietic Stem Cell Transplantation - trends | Europe | Hematopoietic Stem Cell Transplantation - statistics & numerical data | Humans | Patient Care Team - trends | Cord Blood Stem Cell Transplantation - statistics & numerical data | Transplantation, Autologous | Anemia, Aplastic - therapy | Transplantation, Homologous | Patient Care Team - statistics & numerical data | Neoplasms - therapy | Hematopoietic Stem Cell Transplantation - utilization | Tissue Donors - statistics & numerical data | Surveys and Questionnaires | Hematopoietic Stem Cell Transplantation - methods | Transplantation, Haploidentical | Fetal blood | Usage | Research | Hematopoietic stem cells | Stem cells | Index Medicus | Original
Journal Article
Biology of blood and marrow transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 5, pp. 895 - 901
Hematology, Oncology and Palliative Medicine | Bone marrow failure syndromes | Reduced-intensity conditioning | Cyclophosphamide | HLA-haploidentical | Immunodeficiency | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Cyclophosphamide - administration & dosage | Humans | Child, Preschool | Hematopoietic Stem Cell Transplantation | Infant | Male | Adolescent | Adult | Female | Graft vs Host Disease - prevention & control | Unrelated Donors | Transplantation Conditioning | Mycophenolic Acid - administration & dosage | Child | Tacrolimus - administration & dosage | Antimitotic agents | Mortality | Stem cells | Bone marrow | Children | Antineoplastic agents | Health aspects | Hematopoietic stem cells | Immunosuppressive agents | Index Medicus | cyclophosphamide | immunodeficiency | bone marrow failure syndromes
Journal Article
Biology of blood and marrow transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 7, pp. 1299 - 1307
Hematology, Oncology and Palliative Medicine | Stem cell transplantation | Myeloablative | Total body irradiation | Haploidentical | Peripheral blood stem cells | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Haplotypes | Hematologic Neoplasms - therapy | Myeloablative Agonists - therapeutic use | Recurrence | Whole-Body Irradiation | Prospective Studies | Hematologic Neoplasms - mortality | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Risk | Hematologic Neoplasms - pathology | Graft vs Host Disease - immunology | Cyclophosphamide - therapeutic use | Graft vs Host Disease - mortality | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Unrelated Donors | Graft vs Host Disease - etiology | Acute Disease | Histocompatibility Testing | Transplantation, Isogeneic | Tacrolimus - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Survival Analysis | Graft vs Host Disease - prevention & control | Hematologic Neoplasms - immunology | Hematopoietic Stem Cell Transplantation - methods | Transplantation Conditioning | Chronic Disease | Leukemia | Immunotherapy | Mortality | Stem cells | Lymphomas | Mycophenolate mofetil | T cells | Index Medicus
Journal Article
Bone marrow transplantation (Basingstoke), ISSN 0268-3369, 06/2016, Volume 51, Issue 6, pp. 813 - 818
Immunology | Life Sciences & Biomedicine | Hematology | Oncology | Transplantation | Biophysics | Science & Technology | beta-Thalassemia - therapy | Peripheral Blood Stem Cell Transplantation - methods | Humans | Immunosuppressive Agents - therapeutic use | Child, Preschool | Peripheral Blood Stem Cell Transplantation - mortality | Graft Survival | Infant | Survival Rate | Blood Component Removal | Hematopoietic Stem Cell Transplantation - mortality | Transplantation, Haploidentical - mortality | Young Adult | Disease-Free Survival | Homozygote | Transplantation, Haploidentical - methods | Adolescent | Hematopoietic Stem Cell Transplantation - methods | Transplantation Conditioning - methods | Child | Hemoglobin E | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 11/2016, Volume 122, Issue 21, pp. 3316 - 3326
hematologic malignancies | haploidentical transplantation | graft‐versus‐host disease | post‐transplantation cyclophosphamide | 9/10 matched unrelated donors | post-transplantation cyclophosphamide | graft-versus-host disease | Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic Neoplasms - therapy | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Cyclophosphamide - therapeutic use | Transplantation, Homologous | Feasibility Studies | Young Adult | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Unrelated Donors | Drug Therapy, Combination | Graft vs Host Disease - etiology | Histocompatibility Testing | Tacrolimus - therapeutic use | Mycophenolic Acid - therapeutic use | Adolescent | Graft vs Host Disease - prevention & control | Aged | Transplantation Conditioning | Prevention | Usage | Cyclophosphamide | Clinical trials | Graft versus host reaction | Transplantation | Hematopoietic stem cells | Index Medicus | Abridged Index Medicus | 10 matched unrelated donors
Journal Article